Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin + saxagliptin add-on to metformin versus single add-on therapy in poorly controlled type 2 diabetes
2016-005140-41Phase 4Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin, saxagliptin, metformin in type 2 diabetes mellitus (T2DM), sponsored by Azienda Ospedaliero-Universitaria Pisana. Started Jun 2021; status: completed.
02
Drugs
dapagliflozinsaxagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2016-005140-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005140-41.